Breastfeeding and obesity in Brazilian children

Juliana F Novaes1, Joel A Lamounier, Enrico A Colosimo

  • 1Departamento de Nutrição e Saúde, Centro de Ciências Biológicas e da Saúde, Universidade Federal de Viçosa. Viçosa, MG, Brazil. jnovaes@ufv.br

Insights

This study found no significant link between breastfeeding and childhood obesity in Brazil. The research suggests that promoting breastfeeding may not reduce obesity rates in this population, highlighting the need for more research.

Area of Science:

  • Pediatrics
  • Public Health
  • Nutrition Science

Background:

  • The relationship between breastfeeding and childhood obesity remains debated in scientific literature.
  • Previous studies present conflicting evidence regarding the protective effects of breastfeeding against obesity.

Purpose of the Study:

  • To investigate the association between the occurrence and duration of breastfeeding (total and exclusive) and childhood obesity in Brazilian children.
  • To analyze potential confounding factors influencing the breastfeeding-obesity relationship.

Main Methods:

  • A cross-sectional study involving 764 children in Viçosa, Minas Gerais, Brazil.
  • Obesity was defined using World Health Organization (WHO) growth standards (BMI > +2 standard deviations).
  • Multiple logistic regression analysis controlled for numerous child and maternal confounding variables.

Main Results:

  • The prevalence of obesity was 10.7%, with 6.8% of children not breastfed and 59.0% not exclusively breastfed.
  • No statistically significant association was found between breastfeeding occurrence/duration and childhood obesity after adjusting for confounders.
  • No dose-response relationship was observed between breastfeeding duration and obesity prevalence.

Conclusions:

  • The study's findings do not support the hypothesis that breastfeeding promotion reduces obesity in the studied Brazilian population.
  • The inconsistent literature on breastfeeding and obesity underscores the necessity for continued research in diverse populations.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Parentral Nutrition: Centeral and Peripheral Parental Nutrition01:27

Parentral Nutrition: Centeral and Peripheral Parental Nutrition

Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...